Cargando…
Immunological Studies in Acute Myeloid Leukaemia: PHA Responsiveness and Serum Inhibitory Factors
Sera from 16 of 20 patients with AML at some stage of the disease inhibited the in vitro PHA transformation of normal lymphocytes assessed by measuring the rate of DNA synthesis after 67-70 hours; 42% of pretreatment sera were inhibitory. Inhibitory activity was overcome at PHA concentrations 2-3 ti...
Autores principales: | Walker, J. S., Davis, D., Davies, P., Freeman, C. B., Harris, R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1973
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008775/ https://www.ncbi.nlm.nih.gov/pubmed/4511988 |
Ejemplares similares
-
Proceedings: Surface immunological markers in acute myeloblastic leukaemia.
por: Taylor, G. M., et al.
Publicado: (1975) -
Proceedings: Active immunotherapy in acute myeloid leukaemia.
por: Freeman, C. B., et al.
Publicado: (1975) -
Cell-mediated cytotoxicity as a result of immunotherapy in patients with acute myeloid leukaemia.
por: Taylor, G. M., et al.
Publicado: (1976) -
Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020) -
Targeting apoptosis in acute myeloid leukaemia
por: Cassier, Philippe A, et al.
Publicado: (2017)